Cite

HARVARD Citation

    Mandel, V. et al. (2022). Long-term vemurafenib therapy in advanced melanoma patients: cutaneous toxicity and prognostic implications. Journal of dermatological treatment. pp. 1368-1375. [Online]. 
  
Back to record